41![Bulletin # 878 December 20, 2013 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Bulletin # 878 December 20, 2013 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick](https://www.pdfsearch.io/img/75489d50b9b64e95ad3a4b82718c33a0.jpg) | Add to Reading ListSource URL: www.gnb.caLanguage: English - Date: 2013-12-20 10:44:27
|
---|
42![Bulletin #816 July 11, 2011 NBPDP FORMULARY UPDATE This update to the New Brunswick Prescription Drug Program (NBPDP) Formulary is effective Bulletin #816 July 11, 2011 NBPDP FORMULARY UPDATE This update to the New Brunswick Prescription Drug Program (NBPDP) Formulary is effective](https://www.pdfsearch.io/img/7061a4d5de2ddb5bdd65f97761bded3c.jpg) | Add to Reading ListSource URL: www.gnb.caLanguage: English - Date: 2011-07-12 13:14:31
|
---|
43![Microsoft PowerPoint - QNCC Conference Poster (Pawluk) [Compatibility Mode] Microsoft PowerPoint - QNCC Conference Poster (Pawluk) [Compatibility Mode]](https://www.pdfsearch.io/img/d9732abe17225db0d793317c7d8bfb3b.jpg) | Add to Reading ListSource URL: www.qu.edu.qaLanguage: English - Date: 2014-05-21 04:26:36
|
---|
44![Clinical Practice Guideline Clinical Practice Guideline](https://www.pdfsearch.io/img/ab540ef787995b4ee6dee661f593dd1b.jpg) | Add to Reading ListSource URL: www.albertahealthservices.caLanguage: English - Date: 2014-01-14 17:31:09
|
---|
45![C2[removed]Antibiotic Resistance in Lower Respiratory Tract Infection (LRTI) Pathogens: A National Canadian Perspective: The CANWARD Study[removed]Daryl J. Hoban C2[removed]Antibiotic Resistance in Lower Respiratory Tract Infection (LRTI) Pathogens: A National Canadian Perspective: The CANWARD Study[removed]Daryl J. Hoban](https://www.pdfsearch.io/img/981efa2aac91ae23159e6ac59ab8cf7d.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
46![E – 1689 In Vitro Activity of Ceftolozane/Tazobactam Tested Against 5715 Gram-negative and Gram-positive Pathogens Isolated From Patients in Canadian Hospitals in 2011 and 2012: CANWARD Surveillance Study G. G. E – 1689 In Vitro Activity of Ceftolozane/Tazobactam Tested Against 5715 Gram-negative and Gram-positive Pathogens Isolated From Patients in Canadian Hospitals in 2011 and 2012: CANWARD Surveillance Study G. G.](https://www.pdfsearch.io/img/5a3edb40bfe0b60cf7562f3b7aae5ebb.jpg) | Add to Reading ListSource URL: www.can-r.comLanguage: English - Date: 2014-02-24 11:18:11
|
---|
47![sepsis abx pocket July 2011 sepsis abx pocket July 2011](https://www.pdfsearch.io/img/af41dd667075f2819b769217e8061a6e.jpg) | Add to Reading ListSource URL: www.uwmedicine.orgLanguage: English - Date: 2013-10-28 16:21:40
|
---|
48![Percentage of susceptible bacteria, 46 hospitals, Jan - Dec[removed]AMPICILLIN/SULBACTAM PIPERACILLIN/TAZOBACTAM Percentage of susceptible bacteria, 46 hospitals, Jan - Dec[removed]AMPICILLIN/SULBACTAM PIPERACILLIN/TAZOBACTAM](https://www.pdfsearch.io/img/d599d90bb04e72722fdf3235b18a5c4f.jpg) | Add to Reading ListSource URL: narst.dmsc.moph.go.thLanguage: English - Date: 2014-06-24 06:05:09
|
---|
49![Percent Susceptibility of Organisms Isolated From Blood, 44 hospitals , Jan - Dec[removed]PIPERACILLIN/TAZOBACTAM CEFAZOLIN Percent Susceptibility of Organisms Isolated From Blood, 44 hospitals , Jan - Dec[removed]PIPERACILLIN/TAZOBACTAM CEFAZOLIN](https://www.pdfsearch.io/img/c5b5c3240ce7460240c868c6a814abef.jpg) | Add to Reading ListSource URL: narst.dmsc.moph.go.thLanguage: English - Date: 2013-12-13 02:23:37
|
---|
50![Percentage of susceptible bacteria, 29 hospitals, Jan - Mar[removed]AMPICILLIN/SULBACTAM PIPERACILLIN/TAZOBACTAM Percentage of susceptible bacteria, 29 hospitals, Jan - Mar[removed]AMPICILLIN/SULBACTAM PIPERACILLIN/TAZOBACTAM](https://www.pdfsearch.io/img/823c7ea70e4d600f1ddd4e449fb2afd4.jpg) | Add to Reading ListSource URL: narst.dmsc.moph.go.thLanguage: English - Date: 2014-06-24 06:26:06
|
---|